Director
of the Women's Heart Program: Dr. Demopoulos
Dr.
Laura A. Demopoulos, clinical associate
professor of medicine in the Cardiovascular
Medicine Division of the School
of Medicine, has been appointed the
Director of the Women's Heart Program for
the Health System. She practices at Penn
Medicine at Radnor.
"Dr.
Demopoulos brings to Penn a practiced hand
in patient care as well as extensive experience
in clinical trials and patient-oriented
research, and we are delighted she has agreed
to serve as Director of our expanding Women's
Heart Program in the Division," said
Dr. Michael S. Parmacek, chief of the Cardiovascular
Division.
Dr.
Demopoulos, a board-certified physician
in internal medicine and cardiovascular
diseases, came to Penn from Merck and Co.,
Inc., where she was executive director of
the pharmaceutical company's Cardiovascular
Research Department. She has also served
for the past six years as an attending physician
in the Cardiology Fellows Clinic at HUP,
and prior to that served as an attending
physician at Albert Einstein Medical School
in New York.
She
earned her medical degree from NYU and completed
her internship, residency, Chief Residency
and fellowship at NYU Medical Center. She
did research in heart failure at Albert
Einstein College of Medicine in New York
before joining Merck.
Dr.
Demopoulos has held teaching positions at
MIT and at NYU Medical Center and Albert
Einstein. She has conducted extensive research
in the field of cardiology and has contributed
to more than 60 published research articles.
At
Penn Medicine at Radnor, Dr. Demopoulos
is building a multidisciplinary team
that offers medical care designed to
address
the specific needs of women in treating
and preventing heart disease. "Women
have a different onset of symptoms and different
risk factors than men, and so we are creating
a program designed especially for women's
cardiovascular health," Dr. Demopoulos
said. |